- Projects & figures
- News & Events
- Managing your project
- About ERC
About the size of a big cherry, the first-of-its-kind 3D printed heart has cells, blood vessels, ventricles and chambers. This feat is the work of Prof. Tal Dvir and his team at Tel Aviv University. They managed to engineer such miniature organs using cells and biological materials that are originated from human patients. Besides the remarkable technical achievement, this breakthrough could potentially be the answer to the shortage of organ donors in the future.
New families of proteins and enzymes will enable the development of novel plant-based biomaterials, potentially providing viable sustainable and renewable alternatives to plastics and other fossil-fuel-derived materials and chemicals.
ELECTION SERIES #2
Because the European Parliament represents such a diverse group of people, with different cultural and political backgrounds, it is the perfect ground to understand how gender equality operates in the halls of power. ERC grantee Johanna Kantola and her team have shadowed many members of Parliament and their teams, to study gender practices and policies inside Europe’s legislative machine.
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
Based on University of Turku's press release
For more than 3000 years, men have captured wild Asian elephants to use them for work or entertainment. In a new study published today in Nature Communications, ERC grantee Virpi Lummaa shows the harmful effects of these ongoing practices on wild-caught animals. The findings are based on detailed records from the past 100 years over a population of 5000 timber elephants from Myanmar.
Virpi Lummaa holds an Academy of Finland Professorship at the University of Turku, Finland. She is interested in ageing, lifespan and natural selection in contemporary human populations, looking at evolutionary, ecological and demographic factors. At present, Prof. Lummaa also focuses on senescence patterns of the Asian elephant, a long-lived mammal that offers unique opportunities to address ageing mechanisms. Her latest findings highlight the significant role that elephant grandmothers play to ensure the survival of the calves, providing vital baby elephant care comparable to childcare in human communities across the world.Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
Why do so many diabetes patients develop kidney disease, and how can we improve prevention? EU-funded research has examined insulin-related processes at play in impaired renal function — and it may have found a way to protect key cells that help to filter our blood.
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours arise and progress, with a view to identifying biomarkers of our susceptibility to developing cancer. With the ERC grant, the team has created a single-step, early diagnosis kit for colorectal cancer.
The link between capital inputs and success in life are broadly accepted, but very rarely discussed. Professor Jani Erola is using his ERC funding to explore the sociological implications of this relationship. His research concentrates on the complex interaction between a family’s resources and children’s success over the course of their lives: examining how families act collectively to determine the next generation’s achievements. Prof. Erola is a speaker at the 18th World Congress of the International Sociological Association (ISA) which opens on 13th of July in Yokohama, Japan.
By combining computer science and molecular biology, researchers have been able to work on a programmable biological computer that in the future may navigate within the human body, diagnosing diseases and administering treatments. This is what Professor Ehud Shapiro and his team have called a ‘Doctor in a cell’.